BACKGROUND: In general, pulse pressure (PP), augmentation index (AIx), and pulse wave velocity (PWV) are directly and positively associated with cardiovascular risk. However, in patients with systolic heart failure, the opposite (ie, an association between a lower PP and a worse outcome) has been reported as well. METHODS AND RESULTS: We assessed central PP and AIx, using applanation tonometry (SphygmoCor, AtCor Medical) in 63 patients with cardiomyopathy (CMP) and 126 controls, matched for age, gender, and brachial blood pressure (BP). All patients underwent coronary angiography for suspected coronary artery disease. In a subgroup (21 patients, 42 controls), we additionally measured aortic PWV invasively during catheter pullback. Mean age was 63.9 versus 64.1 years and ejection fraction (EF) was 29.9 versus 72.2% in patients versus controls, respectively. Calculated aortic systolic BP as well as invasively measured systolic BP was lower in patients versus controls. Central (but not peripheral) PP (33.8 versus 37.8 mm Hg, P = .01) and AIx (17.5 versus 23.3, P = .002) were lower and ejection duration was shorter (265 versus 314 ms, P < .00001) in patients as compared with controls. When we subdivided the CMP patients with respect to AIx, those with values below and equal to the median (median AIx = 17) had more advanced systolic dysfunction. In multiple regression analysis, EF was an independent predictor of AIx. PVW did not differ between CMP patients and controls (8.6 versus 8.2 m/s in patients versus controls, P = .43). Within the group of CMP patients, however, we observed a strong, positive correlation (r = 0.62, P = .003) between PWV and EF. CONCLUSIONS: Central PP, AIx, but also aortic PWV, key measures of arterial function, are susceptible to left ventricular performance.
BACKGROUND: In general, pulse pressure (PP), augmentation index (AIx), and pulse wave velocity (PWV) are directly and positively associated with cardiovascular risk. However, in patients with systolic heart failure, the opposite (ie, an association between a lower PP and a worse outcome) has been reported as well. METHODS AND RESULTS: We assessed central PP and AIx, using applanation tonometry (SphygmoCor, AtCor Medical) in 63 patients with cardiomyopathy (CMP) and 126 controls, matched for age, gender, and brachial blood pressure (BP). All patients underwent coronary angiography for suspected coronary artery disease. In a subgroup (21 patients, 42 controls), we additionally measured aortic PWV invasively during catheter pullback. Mean age was 63.9 versus 64.1 years and ejection fraction (EF) was 29.9 versus 72.2% in patients versus controls, respectively. Calculated aortic systolic BP as well as invasively measured systolic BP was lower in patients versus controls. Central (but not peripheral) PP (33.8 versus 37.8 mm Hg, P = .01) and AIx (17.5 versus 23.3, P = .002) were lower and ejection duration was shorter (265 versus 314 ms, P < .00001) in patients as compared with controls. When we subdivided the CMP patients with respect to AIx, those with values below and equal to the median (median AIx = 17) had more advanced systolic dysfunction. In multiple regression analysis, EF was an independent predictor of AIx. PVW did not differ between CMP patients and controls (8.6 versus 8.2 m/s in patients versus controls, P = .43). Within the group of CMP patients, however, we observed a strong, positive correlation (r = 0.62, P = .003) between PWV and EF. CONCLUSIONS: Central PP, AIx, but also aortic PWV, key measures of arterial function, are susceptible to left ventricular performance.
Authors: David Marlevi; Jorge Mariscal-Harana; Nicholas S Burris; Julio Sotelo; Bram Ruijsink; Myrianthi Hadjicharalambous; Liya Asner; Eva Sammut; Radomir Chabiniok; Sergio Uribe; Reidar Winter; Pablo Lamata; Jordi Alastruey; David Nordsletten Journal: J Cardiovasc Transl Res Date: 2021-12-09 Impact factor: 4.132
Authors: Raymond R Townsend; Ian B Wilkinson; Ernesto L Schiffrin; Alberto P Avolio; Julio A Chirinos; John R Cockcroft; Kevin S Heffernan; Edward G Lakatta; Carmel M McEniery; Gary F Mitchell; Samer S Najjar; Wilmer W Nichols; Elaine M Urbina; Thomas Weber Journal: Hypertension Date: 2015-07-09 Impact factor: 10.190
Authors: Wilmer W Nichols; Scott J Denardo; Ian B Wilkinson; Carmel M McEniery; John Cockcroft; Michael F O'Rourke Journal: J Clin Hypertens (Greenwich) Date: 2008-04 Impact factor: 3.738
Authors: Ricardo Mora-Rodriguez; Miguel Ramirez-Jimenez; Valentin E Fernandez-Elias; Maria V Guio de Prada; Felix Morales-Palomo; Jesus G Pallares; Rachael K Nelson; Juan F Ortega Journal: J Clin Hypertens (Greenwich) Date: 2017-11-06 Impact factor: 3.738